Detalhe da pesquisa
1.
Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action.
Eur J Immunol
; 51(3): 544-556, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33450785
2.
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial.
Lancet Oncol
; 20(3): 383-393, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745090
3.
Potential for monocyte recruitment by IgE immunotherapy for cancer in a rat model of tumour metastasis.
Lancet
; 385 Suppl 1: S53, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26312875
4.
Beta-glucan contamination of pharmaceutical products: How much should we accept?
Cancer Immunol Immunother
; 65(11): 1289-1301, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27473075
5.
The role of the HGF/Met axis in mesothelioma.
Biochem Soc Trans
; 44(2): 363-70, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27068941
6.
Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti-tumor IgE therapeutic candidate.
Allergy
; 75(8): 2069-2073, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32086828
7.
AllergoOncology: Expression platform development and functional profiling of an anti-HER2 IgE antibody.
Allergy
; 74(10): 1985-1989, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30964550
8.
Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology.
J Allergy Clin Immunol
; 141(4): 1519-1523.e9, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29360527
9.
Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application.
Cancer Immunol Immunother
; 61(9): 1547-64, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22139135
10.
Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4.
J Biol Chem
; 285(33): 25538-44, 2010 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20562098
11.
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer.
Cancer Res
; 81(16): 4290-4304, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224371
12.
Harnessing Therapeutic IgE Antibodies to Re-educate Macrophages against Cancer.
Trends Mol Med
; 26(6): 615-626, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32470387
13.
IgE Antibodies against Cancer: Efficacy and Safety.
Antibodies (Basel)
; 9(4)2020 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33081206
14.
A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma.
Cancers (Basel)
; 12(4)2020 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32331483
15.
In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model.
MAbs
; 12(1): 1685349, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769737
16.
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies.
Front Immunol
; 11: 622442, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569063
17.
IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype.
Cancers (Basel)
; 12(11)2020 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203088
18.
Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs).
Sci Rep
; 10(1): 8869, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32483228
19.
Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome.
Cells
; 9(7)2020 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645919
20.
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer.
Clin Cancer Res
; 26(6): 1220-1228, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796521